To investigate whether HER2 was overexpressed in BCSCs from HER2-negative breast cancer cells, we first sorted the CD44high/CD24low, a marker for BCSCs [16], population from HER2-negative breast cancer MCF7 cells (Figure 1A). Here, ERBB2 is linked to breast carcinoma.